CARDONE, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 377
AS - Asia 210
NA - Nord America 209
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 13
Totale 823
Nazione #
RU - Federazione Russa 294
US - Stati Uniti d'America 202
SG - Singapore 84
CN - Cina 50
IT - Italia 43
HK - Hong Kong 31
IE - Irlanda 20
VN - Vietnam 15
DE - Germania 11
BR - Brasile 10
IN - India 10
KR - Corea 8
CA - Canada 4
JP - Giappone 4
EC - Ecuador 3
NL - Olanda 3
CR - Costa Rica 2
PL - Polonia 2
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
PH - Filippine 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
Totale 810
Città #
Moscow 105
Singapore 43
San Jose 37
Hong Kong 29
Santa Clara 26
Ashburn 22
Dublin 18
Council Bluffs 11
Beijing 10
Hefei 9
Naples 9
New York 9
Chandler 8
Seoul 8
Hanoi 7
Dallas 6
Los Angeles 6
Milan 6
Bengaluru 5
Aversa 4
Brooklyn 4
Munich 4
Amsterdam 3
Atlanta 3
Ho Chi Minh City 3
Sant'Antimo 3
Berlin 2
Bremen 2
Cambridge 2
Florence 2
Giugliano in Campania 2
Hyderabad 2
Middletown 2
Montreal 2
Princeton 2
Rome 2
Roxbury 2
San José 2
Shanghai 2
São Paulo 2
Warsaw 2
Amman 1
Baku 1
Bishkek 1
Bologna 1
Brno 1
Cali 1
Cascavel 1
Cercola 1
Chengdu 1
Chennai 1
Da Nang 1
Denver 1
Des Moines 1
El Paso 1
Falkenstein 1
Guangzhou 1
Guayaquil 1
Haikou 1
Hinesville 1
Houston 1
Iporá 1
João Pessoa 1
Kayseri 1
Lawrenceville 1
Levittown 1
Limburg an der Lahn 1
Longi 1
Manado 1
Manchester 1
Memphis 1
Miano 1
Mobile 1
Mumbai 1
Murfreesboro 1
New Delhi 1
Newark 1
Oeiras 1
Orem 1
Pataskala 1
Petersburg 1
Ponta Porã 1
Pozzuoli 1
Poções 1
Qingdao 1
Queens 1
Quito 1
Riyadh 1
San Diego 1
Secaucus 1
Seropédica 1
Sherbrooke 1
St Petersburg 1
Stockholm 1
São Bernardo do Campo 1
Taiyuan 1
The Bronx 1
The Dalles 1
Thái Nguyên 1
Tokyo 1
Totale 487
Nome #
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial 172
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 163
Pimasertib hydrochloride 149
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 148
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 147
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer 44
Totale 823
Categoria #
all - tutte 2.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 4 3 0 0 2 1 4
2022/202332 3 0 1 1 6 2 0 2 12 0 3 2
2023/202430 3 0 1 0 7 6 3 2 1 0 2 5
2024/2025114 2 3 0 14 18 16 18 14 10 5 3 11
2025/2026551 18 26 25 10 42 277 30 33 30 16 31 13
2026/202782 4 12 27 39 0 0 0 0 0 0 0 0
Totale 823